SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 93.48+1.0%Oct 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (3132)6/8/2017 1:05:21 PM
From: scaram(o)uche   of 3202
 
I need a list of combo's that have failed. And I hate having to google a trade name, to find a specificity or mechanism of action.

I need the sort of tables that I once kept.

:-(

I am focused on combo's that don't involve direct T cell activation or even regulation (monocytes, MDSCs, all of the stuff that hasn't worked from an investment stand), unless it's through vaccination... antigen-specific. In that regard, you could goose your trade with a discussion of those outrageously provocative (ugh) provenge results? Adjunct asst. professor. But, would have looked like a phase II holy grail, ten years ago.

Discussion of those results? Looks like it's touching an electrified third rail.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News